Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 18/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 15/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 2/20 | 1.00 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 1.00 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 1.00 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL529065 | 1.00 | HDAC3 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1938496 | 1.00 | HDAC3 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1937829 | 0.99 | HDAC3 (0.98) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1938110 | 0.88 | HDAC3 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1938122 | 0.88 | HDAC3 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1938221 | 0.88 | HDAC3 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1937223 | 0.88 | HDAC3 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL16011065 | 0.88 | HDAC4 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1937932 | 0.88 | HDAC3 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 | |
| SCHEMBL1937980 | 0.88 | HDAC1 (1.00) | HDAC3HDAC1HDAC2NCOR2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |